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The protein α-Synuclein (αS) is associated with varioussynucleinopathies including Parkinson’s disease throughits abnormal aggregation, fibril formation, and formation
of Lewy bodies1–4. Although its exact native function is not yet
fully understood, αS is found in synaptic vesicles and supposed to
be involved in membrane interactions, e.g., in synaptic vesicle
homeostasis5,6 and SNARE-like vesicle-to-vesicle or vesicle-to-
membrane fusion7,8. Membrane association of αS has been shown
to modulate its aggregation propensity9,10 and αS oligomeric
species have been proposed to be the toxic species in Parkinson’s
disease, especially through membrane pore formation mechan-
isms11,12. Notably, αS has been shown to be specifically acetylated
at its N-terminus, which is thought to act as an important mode
of regulation of protein–membrane association13,14.
Previous data recorded using micelle and vesicle preparations
already provided valuable information of the αS–membrane
interactions, including binding and lipid specificity15–18, effect of
mutations on membrane association8,19, micelle-bound struc-
ture20, vesicle-bound structural insights21–23, and conformational
dynamics8,23,24. Two structural models of lipid-bound αS were
proposed, i.e., the “extended helix” consisting of one roughly 100-
residue-long α-helix25 and the “horse-shoe” consisting of two
helices with different lipid affinities separated by a kink at resi-
dues 42–4426. Furthermore, various effects of lipids for αS
aggregation were reported including inhibition of aggregation27,
triggering of fibrillation28,29, and modification of fibril struc-
ture29. Membrane binding and its effect on aggregation have been
shown to be strongly dependent on chemical properties of the
lipids including head group charge content26 and fatty acid
type30.
Although the phospholipid bilayer nanodisc (NDs) system31
does not fully resemble the physiological properties of synaptic
vesicle membranes in all aspects (e.g., absence of curvature and
integral membrane proteins), it offers the potential to provide
additional insights that are complementary to the information
obtained, e.g., on micelles or liposome preparations. Notably,
NDs have been used before to study the effect of calcium ions on
the membrane interaction of αS32, as well as lipid and monomer
specificity of the Alzheimer-associated Aβ peptide33. In general,
NDs are very homogeneous, stable in a wide buffer range34, and
allow the preparations of well-defined lipid mixtures with an
accurate estimate of the bilayer size35, charge36, and lipid
molarity37. The increased stability may, e.g., offer the possibility
to determine the interaction with a stable planar bilayer surface.
In contrast, it is known for small unilamellar vesicles (SUVs) that
the interaction with αS can considerably and rapidly change the
lipid environment (e.g., from homogeneous SUVs to rather
heterogeneous particles8,38–40). In addition, the smaller size of the
NDs should, in theory, allow the detection of the lipid-bound
state using suitable solution nuclear magnetic resonance (NMR)
techniques34,41,42. In general, the well-defined size and lipid
composition of NDs, paired with their accessibility, homogeneity,
and stability should permit unique quantitative insights into αS
membrane association and its role in aggregation.
Here we explore this potential and report on a comprehensive
NMR investigation of the effects of lipid charge, bilayer fluidity,
and αS N-terminal acetylation on the structural aspects of αS
membrane association. We corroborate these insights with
molecular dynamics (MD) simulations and a series of com-
plementary biophysical measurements to further characterize
membrane plasticity, global affinities, as well as binding and
aggregation kinetics. Based on this data we correlate structural
insights, such as residue-specific affinities and competition for
accessible membrane surface area, to their potential role in
modulating αS aggregation properties. Our study provides
insights into (i) the different lipid binding modes of αS to stable
planar bilayers of defined lipid quantity and composition,
(ii) the effect of membrane plasticity for αS binding, (iii) the
modulation of membrane plasticity through αS, and (iv) the
connection between binding modes and their effect on αS
aggregation. In addition, it gives an initial estimate of the
number of lipid molecules and of lipid-associated αS molecules
that are required to induce fibril nucleation, and allows to develop
a basic structural and kinetic model of the modulation of αS
aggregation through its interaction with different membrane
surfaces. Our in vitro data help to better understand the mole-
cular determinants of αS–membrane association and may point
to possible in vivo implications in the context of Parkinson’s
disease.
Results
αS membrane-modulated aggregation due to lipid charge. To
obtain residue-specific insights into the interaction of αS with
lipid bilayer NDs of various composition, we recorded a series of
solution NMR two-dimensional transverse relaxation optimized
spectroscopy (TROSY)-heteronuclear single quantum coherence
(HSQC) spectra keeping a molar ratio of one αS molecule
per membrane leaflet (Fig. 1a). In the presence of NDs
containing only 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC) lipids, no differences to the spectrum of αS in the
absence of NDs were detected (Fig. 1a–c, black). This finding
shows that αS does not interact with the membrane scaffold
protein and provides additional evidence that αS does not interact
with non-charged lipid bilayers. In a similar way as reported
previously using liposomes26,43, we further tested the influence of
increasing amounts of negatively charged lipid head groups on αS
membrane association (Fig. 1a–c). It is noteworthy that lipid
ratios and proper mixing of the different lipid types inside the
NDs were also verified by NMR spectroscopy (Supplementary
Fig. 1a). When increasing the content of the negatively charged
lipid 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol)
(POPG) our NMR data show a gradually increasing bilayer
interaction of αS, as evident by a residue-specific decrease in the
ratio of NMR signals in the presence and absence of NDs. This
NMR attenuation profile divides the protein into rather distinct
regions with different membrane-binding behaviors (Fig. 1b, c).
The first region spans the N-terminal residues 1–38, which are
already weakly interacting at 25% content of negatively charged
lipids and strongly interact at 50% (or higher) charge content. A
comparison between αS that is acetylated at its N-terminus
(Fig. 1b) and non-acetylated αS (Fig. 1c) shows that, in particular
at lower anionic lipid content the N-terminus does interact
stronger with the membrane when it is acetylated, which is in line
with previous data observed on SUVs14. While we recorded most
data for both αS forms, unless otherwise stated, only data
obtained on the more physiologically relevant acetylated αS will
be shown in the following. Data recorded on non-acetylated αS
along with a more detailed discussion can be found in the Sup-
plementary Information (Supplementary Fig. 2).
At 50% charge content, the region comprising residues 38–60
also gradually starts to interact. Amino acids 60–98, correspond-
ing approximately to the aggregation-prone non-amyloid-β
component (NAC region), display some interactions with
membranes containing 75% anionic lipids and strongly interact
at 100% anionic lipid content. The 98–120 region is
(partly) affected by 100% net charge content only. Finally, the
last 20 C-terminal residues never show any membrane interaction
(see Fig. 1d for a model of the different binding modes). This
data is largely in line with a predominantly electrostatic model44
(the first 60 residues displaying a net positive charge, the last 40
residues a net negative charge, and the NAC region being mostly
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hydrophobic), as well as the three regions dynamic model
reported before using SUVs23.
Interestingly, a comparison with the previously published data
on SUVs that observe similar negative charge-dependent binding
modes for vesicle-bound αS using electron paramagnetic
resonance (EPR) and NMR26,45, suggests that factors such as
membrane curvature, potential instability of liposomes, or the
physical borders introduced by the scaffold proteins, which
should prevent formation of a fully extended αS α-helix on the
membrane surface, do not have a large effect on the detected αS
membrane association (see below for more detailed discussion on
binding modes; also see Supplementary Note 1 for more detailed
discussion on NDs stability).
Using Thioflavin T (ThT) fluorescence as a reporter for fibril
formation, we also measured aggregation kinetics of αS in the
absence and presence of the different ND compositions (Fig. 1e).
These aggregation assays were recorded using identical protein
and ND concentrations, as well as buffer conditions as used for
the NMR measurements, facilitating a direct comparison
between membrane-binding modes and their consequences for
protein aggregation. It is noteworthy that, unless stated
otherwise, an aggregation assay setup was chosen that mainly
reports on the consequences of ND interactions with the lipid-
independent aggregation pathway of αS46–49 (see Methods for
more details).
Interestingly, despite the fact that the NMR data show
interaction, the presence of NDs up to an anionic lipid content
of 50% does not appear to affect aggregation kinetics of acetylated
αS. When increasing the negative charge content to 75%, the
aggregation half-time slightly increases (Fig. 1e, dark blue) and a
strong aggregation-inhibiting effect is detected in the presence of
NDs with 100% anionic lipids (Fig. 1e, purple). A comparison of
the ThT kinetic data with the NMR-detected modes of αS binding
to membranes of different charge contents allows to link
molecular determinants of membrane association to their possible
effects on αS aggregation. One of the most striking connections is
that αS interaction with NDs comprising up to 50% negatively
charged lipids does not involve the NAC region, and that under
the same conditions no detectable effect on the aggregation
behavior of (acetylated) αS is found in ThT assays. When further
increasing the charge density above 50% negatively charged
lipids, NMR data show first a partial (75% POPG, Fig. 1a–c, dark
blue) and then a full (100% POPG, Fig. 1a–c, purple) signal
attenuation of the NAC region. This membrane interaction of the
NAC region correlates with a slight inhibitory effect of the 75%
charged NDs on αS aggregation (Fig. 1e dark blue) and a very
strong inhibitory effect of 100% charged NDs (Fig. 1e, purple).
Therefore, our data strongly suggest that for the tested conditions
(high anionic lipid content and high lipid-to-αS ratios)
membrane association of the NAC region protects αS from
aggregation.
The ND-bound state of αS. It is noteworthy that, despite possible
in principle34, we could not detect the ND-bound conformation
of αS by solution NMR (see Supplementary Fig. 3 and Supple-
mentary Note 2 for more detailed discussion). In order to still
gain insight into the conformation of αS bound to NDs, we used
magic angle spinning solid-state NMR. Moreover, we took
advantage of the very low temperatures (100 K) used in dynamic
nuclear polarization (DNP) to additionally eliminate exchange
processes and to increase the sensitivity of the experiment. To
avoid problems of signal overlap arising from severe inhomoge-
neous line broadening often seen in this range of temperatures50,
we used a sparse isotope labeling scheme51, leading to the
simplification of 13C–13C spectra to secondary structure-sensitive
Cα–Cβ cross-correlations of valines (and leucine Cβ–Cγ).
Notably, according to the αS primary sequence and our solution
NMR observations (Fig. 1a–c), 95% of the valine residues (i.e., 18
out of the 19) should be membrane bound at the used charge
content (100%) and αS-to-ND ratio (1:2). Although in the
absence of NDs the DNP 13C–13C spectrum shows a continuous
distribution of the valine Cα–Cβ cross-peaks reflecting the carbon
chemical shifts of the allowed Ramachandran space (expected for
an intrinsically disordered protein such as αS, see Fig. 2, black), a
very strong peak shift to a defined chemical shift range typical for
α-helical structure is visible after addition of NDs (Fig. 2, purple).
The DNP data thus show that αS binds the NDs in α-helical
a
~98










































































































Fig. 1 Lipid charge content modulates αS membrane binding modes and different binding modes show different effects on αS aggregation. a NMR [15N-1H]-
TROSY-HSQC spectra of [15N]-αS (50 µM) in the absence (gray) or in the presence of 25 µM NDs containing an increasing amount of the anionic lipid
POPG complemented with the zwitterionic lipid DMPC (0% POPG (black), 25% POPG (light blue), 50% POPG (blue), 75% POPG (dark blue), and 100%
POPG (purple)). Selected residue assignments corresponding to differently affected parts of αS are indicated. Corresponding NMR attenuation profiles, i.e.,
the ratio of peak volumes in the presence and absence of NDs, are plotted against αS primary sequence for acetylated b and non-acetylated c αS. d
Molecular model visualizing the gradual binding of different parts of αS to NDs with increasing charge content. White arrows and transparent coloring
indicate αS regions that experience intermediate NMR-signal attenuation indicative of multiple (dynamic or static) states. e αS aggregation assays
(normalized ThT fluorescence) in the absence and presence of NDs with indicated POPG content for acetylated αS (concentration of αS and NDs identical
to NMR data in a–c, data of triplicate measurements until reaching saturation and their respective fits are shown, color code as in a–c)
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conformation corroborating previous studies using circular
dichroism (CD) spectroscopy of vesicles, solution NMR spec-
troscopy of detergents micelles, and solid-state NMR
spectroscopy of SUVs20,23,29. Interestingly, in contrast to SUVs
the lipid bilayer of the NDs system does have a defined edge that
can act as physical barrier for the αS membrane interactions.
Geometrical considerations suggest that a fully extended α-helix
with about 60 residues will completely span the diameter of one
ND. Therefore, either the formation of a significantly bent helix
(parallel to the membrane scaffold proteins) or at least one kink
in the helix is compulsory for the largest observed ND-binding
modes. The presence of rather defined steps in the NMR
attenuation profiles for 50% and 75% POPG content (Fig. 1b, c)
would be in line with the latter and could indicate possible kink
positions (as visualized in Fig. 1d). The high similarity to the
previously reported SUV-binding modes suggest that αS, in a
similar manner as the so-called “horse-shoe” model22, has an
intrinsic propensity to form the necessary kink in the membrane-
binding interface.
αS membrane-modulated aggregation due to lipid phase. To
further investigate the effect of different lipid properties we
recorded NMR spectra of αS in the presence of NDs containing
different lipids and lipid mixtures. The data recorded with 100%
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, one
unsaturation, neutral charge) NDs do not show interaction
(Fig. 3a, gray), comparable to 100% DMPC (no unsaturation,
neutral charge) NDs (Fig. 1a–c, black). We also used all combi-
nations of binary lipid mixtures of DMPC, 1,2-dimyristoyl-sn-
glycero-3-phospho-(1′-rac-glycerol) (DMPG), POPC, and POPG,
with an overall net charge content of 50%. Our data show that the
heterogeneous mixtures DMPG/POPC and POPG/DMPC, and
the homogeneous POPG/POPC mix behave very similarly
(Fig. 3a), suggesting that the position of charge with respect to
fatty acid as well as the ‘surface roughness,’ as potentially intro-
duced by heterogeneous chain lengths, has little effect on
αS–membrane interaction.
Interestingly, a mixture of fully saturated lipids (dimyristoyl
lipids) with 50% charge content does not considerably interact
with αS (Fig. 3b, beige). At the temperature of the NMR
experiments (10 °C), the bilayer formed by saturated dimyris-



































Fig. 2 Nanodiscs binding induces α-helical structure in αS. [13C-13C]-Proton
driven spin diffusion magic angle spinning-DNP spectra of free non-
acetylated αS in frozen solution (black) and when bound to NDs with 100%
POPG lipids (purple). Selective isotope labeling was used to specifically
monitor valine Cα-Cβ chemical shift distributions. Peak positions indicative
of β-sheet and α-helical secondary structure are labelled. The insert shows
normalized 1D projections of the highlighted region (dashed square) in the
absence (black) and presence of 100% POPG NDs. Signal deconvolution of
these spectra reveals that about 92% of the valines are in an α-helical
configuration in the presence of 100% POPG NDs. The occurrence of valine
residues in the αS sequence is shown on top (blue lines). According to the
respective solution NMR attenuation profile (Fig. 1c, purple) 18 out of 19
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Fig. 3 αS–lipid interaction is favored by increased membrane plasticity.
[15N]-αS (50 µM) NMR attenuation profiles in the presence of 25 µM NDs
with indicated lipid composition (molar ratio 2:1, αS-to-NDs) for bilayers
that are in a more fluid a or gel phase b at 10 °C. It is noteworthy that all
NMR data are recorded at 10 °C and pH 7.4 with the exception of one of
the 100% DMPG samples (b, red bars) that was recorded at 37 °C and pH
5.3. c Corresponding ThT aggregation assays (50 µM αS, 25 µM NDs) for
selected conditions (for better visibility only the mean values of triplicate
measurements are shown, colors correspond to respective attenuation
profiles in a, b)
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the gel phase (Tm around 28 °C, Supplementary Fig. 1d). When
increasing the charge content to 100%, but remaining in the gel
phase (100% DMPG, Fig. 3b, brown), αS shows a clear interaction
with the membrane resembling a binding mode that is found for
50% charge content in the fluid phase. This data is well in line
with previous CD data on SUVs that identified an important
role of the lipid phase for αS–lipid interaction30. Although
increasing the temperature for the NMR measurements above
Tm leads to a previously observed loss of NMR signals due to
amide-water exchange processes for most relevant residues,
lowering the pH from 7.4 to 5.3 can counter this effect
(Supplementary Fig. 3c-f). The respective NMR data show that
αS forms a much larger binding interface with DMPG lipids in
the fluid phase (Fig. 3b, red-brown bars, only peaks with easily
transferable resonance assignments are plotted), in line with
previous findings using vesicles30,44, providing residue-specific
insights into the modulation of αS membrane-binding modes
by lipid phase properties.
Taken together, these data on αS–lipid association can be
summarized as follows: (i) unsaturations in the hydrocarbon
chains, leading to increased membrane fluidity, are not sufficient
to induce binding; (ii) the presence of heterogeneity in fatty acid
chains and the combination of charge and unsaturation on the
same lipid molecule are not critical; and (iii) in addition to
charge, a lipid phase state that introduces an increased membrane
fluidity is important for binding.
We also performed ThT aggregation assays with NDs
containing selected lipid mixtures as investigated by NMR. All
mixtures that contain 50% negatively charged lipids, indepen-
dently of acyl chain heterogeneity or charge position, show
consistently unaffected aggregation behavior (Fig. 3c). However,
αS aggregation is drastically impeded in the presence of 100%
DMPG NDs (Fig. 3c, red-brown). As aggregation assays were
measured at 37 °C, our NMR data (Fig. 3b, red-brown) show that
αS is in a lipid-binding mode, which involves the NAC region and
therefore is expected to inhibit aggregation.
αS and membrane plasticity: a two-way street. It is apparent that
the initial N-terminal αS residues comprise a central lipid-binding
motif with key features highly suitable for interactions with a
charged lipid surface45,52, and that these residues form a helical
secondary structure after binding16,23,29. Based on the exposed
and symmetric distribution of lysine residues, the occurrence of
hydrophobic residues on one side of the helix and the distribution
of negative charges on the opposite side (Fig. 4a), it is tempting to
speculate that αS adopts a lipid-interacting conformation as
shown in Fig. 4b. In this picture, it would be likely that the lipids
Lys 10







Lys 58 Lys 60
a





750 800 850 900 950
































750 800 850 900 950

























































Fig. 4 αS–lipid interaction potentially modulates membrane plasticity. a Molecular features of αS’s key lipid binding mode (residues 1–38), including
periodically and symmetrically appearing lysine residues (blue) that form a positively charged “grid” (see text for more details). b Model of αS1-61-nanodisc
interaction (drawn to scale), lysine (blue) and negatively charged residues (red) are highlighted. c αS-to-lipid contacts ( < 4 Å) per residue as occurring
during the time course of MD simulations. Normalized values for interactions with anionic lipids (upper diagram) or neutral lipids (lower diagram)
differentiating between lysines and all other residues as well as between gel/fluid-phase membranes (beige/yellow bars), respectively. d Bilayer thickness
(upper panels) and area per lipid (lower panels) during the end of MD simulations in the presence (solid lines, three independent simulations) and in the
absence of αS (dashed line). While simulations in the gel phase show no considerable effect (d, left panels), a clear trend toward a more ordered state for
the fluid phase membrane, induced by the presence of αS, is visible by an increase bilayer thickness and reduced area per lipid (d, right panels)
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Fig. 5 The interplay between interaction kinetics, differential residue specific affinities, membrane charge density and accessible surface area modulates αS
aggregation. a BLI sensorgrams obtained with immobilized 100% POPG NDs and addition of different concentrations of αS. Corresponding steady-state
response plot are shown as insert. A fitted global affinity (KD) of 67 ± 17 nM and a fitted off-rate of 0.015 ± 0.006 s−1 could be extracted. b NMR
attenuation profiles of a titration of 50 µM αS with varying concentrations of 100% POPG NDs (αS-to-NDs molar ratios ranging from 16:1 to 1:1, see color
code). c Corresponding residue-specific affinities extracted from NMR titration data. The values report on the slow-exchange (lower) limit for the affinities
(see text for details). d Normalized ThT fluorescence aggregation curves for selected αS-to-ND ratios (conditions identical as in b–g). e NMR-derived
binding modes and their link to the indicated aggregation behaviour (see Supplementary Note 3 for more details on how binding models were generated).
Although high amounts of NDs with high charge density inhibit aggregation (binding mode II), limited amounts of highly charged membrane surfaces
enhances aggregation (binding mode I). For NDs with a moderate lipid charged density, only one αS-binding mode was observed that has little effect on
aggregation (binding mode III). f Nucleation ThT assays in quiescent conditions at pH 5.3. Although under these conditions no aggregation is observed in
the absence of NDs (duplicates in gray), the presence of 16:1 molar ratio of 100% POPG NDs (duplicates in light and dark blue) induces primary nucleation.
g–i Same as data shown in b–d but using NDs with 50% POPG content
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and the lysine side chains (partly) rearrange, from their
“unbound” conformation, to ideally accommodate electrostatic
interactions. In line with our NMR results, this rearrangement
may be favored by a more fluid lipid phase.
To test this hypothesis, we performed MD simulations of
αS–membrane interactions. Our simulations focus on the first 61
residues of αS and their interactions with membranes formed by a
mixture of either 50% POPG–50% POPC lipids in the fluid phase
or a 50% DMPG–50% DMPC mix in the gel phase. The MD data
confirm that lysine residues have a key role in the membrane
interaction, as, e.g., visible by forming considerably more contacts
to anionic lipids as compared with other residues (Fig. 4c, upper
diagram). In addition, a generally stronger interaction of αS with
the anionic lipids in the fluid membranes (POPG) is detected, as
compared with the gel-phase membranes (DMPG) (Fig. 4c,
yellow vs. beige). Noteworthy, these effects are much less
pronounced for contacts to the neutral lipids (Fig. 4c, lower
diagram). These findings correlate well with the effects of lipid
charge and membrane plasticity seen in the NMR and
aggregation assays.
Interestingly, the MD data also report on the effect of αS
interaction from the lipid point of view. According to this data,
the well-ordered DMPC/PG lipids (gel phase) experience very
small effects due to the presence of αS. These MD results are in
line with only small effects seen in differential scanning
calorimetry profiles that we recorded on gel-phase NDs in the
presence and absence of αS (see Supplementary Fig. 1e). On the
other hand, for MD simulations of less ordered POPC/PG lipids
(fluid phase), the presence of αS induces a considerably more
ordered lipid state as evident by an increased bilayer thickness,
reduced surface area per lipid, and increased order parameters for
the hydrocarbon chains (Fig. 4d and Supplementary Fig. 4). In
general, the MD data suggest that αS–membrane interaction is
(initially) facilitated by increased membrane plasticity, e.g., via
more contacts found in the fluid phase. These interactions may
consequently confine lipids and lead to reduced membrane
plasticity. The latter is in line with recent experimental data
showing that αS binding can increase lipid packing53,54, an effect
that has also been suggested to have a role in αS function as
chaperone for SNARE-mediated vesicle fusion55.
The role of affinities and kinetics. In addition to modulation of
binding modes due to lipid charge and membrane plasticity we
were also interested in αS membrane-binding affinities and
kinetics. We therefore measured interaction kinetics and
thermodynamics using biolayer interferometry (BLI) with
immobilized NDs of different charge contents. In line with the
NMR data, no αS binding was detected when NDs containing
100% DMPC were immobilized. When NDs with 100% anionic
lipid content were immobilized, a clear response upon addition of
different αS concentrations was observed (Fig. 5a), enabling a
quantitative description of the membrane association with an
overall dissociation constants KD of 67 ± 17 nM (one αS to one
ND) and a slow off-rate of 0.015 ± 0.006 s−1.
In order to obtain residue-specific insights into the membrane
affinity of αS, we additionally conducted NMR titration
experiments using 100% negatively charged NDs (Fig. 5b). In
general, affinities (KD) can be extracted from NMR titrations
attenuation profiles by fitting the concentration dependency of
the attenuation with a single exponential decay for each resolved
peak (corresponding to one assigned residue in a two-state
binding model, i.e., unbound and membrane attached). This
method is valid under the assumption of a pure slow exchange
regime. Although the BLI data clearly point to the presence of
slow exchange processes, contributions from intermediate
exchange are still to be expected for residues showing weaker
membrane interactions, i.e., residues located in the central region
of αS. For these residues, the applied method does not provide
accurate quantitative values; nevertheless, a qualitative trend can
still be extracted. It is noteworthy that the underestimation of
exchange contributions will generate lower KD values and hence
the obtained values can be seen as a lower limit. The resulting
slow-exchange-biased affinities (KD,slow-ex) are plotted in Fig. 5c
and reveal differential membrane affinities for different regions of
the αS primary sequence. As discussed above due to the
slow-exchange bias, the differential affinities of αS are probably
even larger. It is noteworthy that the regions with differential
affinities for highly charged membranes largely overlap with the
different binding modes induced by different charge densities
identified before (Fig. 1b).
Due to the geometry of the used NDs, up to five αS molecules
can simultaneously bind with a 38-residue long α-helix (first
binding mode) to one side of one ND. If 8 molecules are
accommodated together on the surface, (on average) a 23-residue
long helix per monomer could be formed. The observed
differential affinities are therefore a direct consequence of the
competition of different monomers for accessible membrane
surface area. As a result, membrane association of the weaker
interacting NAC region is strongly dependent on the accessibility
of negatively charged membrane surface. Importantly, it appears
that one ND with 100% negatively charged lipids can simulta-
neously interact with about 16 αS molecules (8 per ND side) in
the course of the NMR time scale, as seen from the complete
disappearance of the signals of the very N-terminal residues
(Fig. 5b, light blue). This means that under this condition the
membrane surface brings several αS molecules, with nearly fully
exposed NAC regions, in close spatial proximity.
To characterize the effect of the accessible membrane surface
area on αS aggregation behavior, we measured ThT aggregation
kinetics on samples with different αS-to-ND ratios by decreasing
the ND concentration at constant αS concentrations (Fig. 5d).
Interestingly, a higher ratio of αS-to-ND leads to a prominent
decrease in aggregation lag times when using 100% POPG NDs
(Fig. 5d, blue and cyan). These data show, in line with previously
reported behavior on SUVs28,29, that under specific conditions
lipid bilayers can accelerate the fibrillation process. Our NMR
data allow to link these conditions, i.e., limited membrane surface
area with a high charge density, to an αS–lipid-binding mode that
brings several αS molecules with exposed NAC regions in close
proximity (binding mode I in Fig. 5e).
In order to disentangle the effect of NDs on the nucleation or
the elongation step in the αS aggregation pathway, we used ThT
assays predominantly reporting on the one or the other
(see methods for more details of assay design). Nucleation-
sensitive assays in the presence of 100% POPG NDs and an αS-
to-ND ratio of 16:1 indeed show that the underlying membrane
association (binding mode I in Fig. 5e) enhances primary
nucleation (Fig. 5f, blue). Interestingly, as our data also allow
an estimation of the total number of αS monomers that are
brought in close proximity due to their interaction with the same
ND (i.e., up to 8 monomers per bilayer side, Fig. 5b blue), this
result may also provide a first approximation of the number of αS
monomers needed for the formation of a nucleus. As discussed
above, our data suggest that this “minimal critical nucleation
number” has an upper limit of around 8 αS molecules. It is
noteworthy that this number is only an initial estimate and may
be influenced by dynamic processes as well as local fluctuations,
which may lower or increase the value by a few monomers.
Fibril elongation-sensitive aggregation assays carried out in the
presence of 100% POPG NDs (Supplementary Fig. 5c, d) show no
effect on elongation rates for αS-to-ND ratios of 16:1 (binding
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mode I in Fig. 5e). However, a clear reduction in elongation rates
with decreasing αS-to-ND ratio is visible, which is largely in line
with sequestering monomers, in particular accessible NAC
region, out of solution (Supplementary Fig. 5c, d). No fibril
elongation is observed for αS with a fully membrane-bound NAC
region (binding mode II in Fig. 5e) consistent with the overall
aggregation-inhibiting properties of this condition. Noteworthy,
unlike in the case of SUVs29, atomic force microscopy (AFM)
images of αS fibrils formed in the absence or presence of NDs do
not show different morphology (Supplementary Fig. 6). This,
however, does not exclude that (a limited amount of) lipids are
also incorporated into the fibrils (see Supplementary Fig. 6 and
stability considerations for more detailed discussion).
We additionally carried out the same BLI measurements, NMR
titrations, and ThT assays for ND containing only 50% POPG
lipids.
For these NDs, no clear signature of binding could be obtained
in the BLI measurements, suggesting a weak affinity and/or too
fast off rates to allow detection via BLI. This is in line with size
exclusion chromatography (SEC) profiles that also point to a
more transient interaction (Supplementary Fig. 1b, c).
NMR titrations, however, show clear concentration-dependent
attenuation profiles that allow the calculation of (slow-exchange-
biased) residue-specific affinities (Fig. 5g, h). Noteworthy, the
NMR attenuation profiles and affinities for the αS residues in the
first binding region (residues 1–38) are comparable to the values
obtained for 100% charged NDs (Fig. 5b, c). In contrast, for the
following binding regions much lower affinities are found (at the
edge of detection for residues 39–60 and no interaction for
residues > 60), including the absence of interactions of the NAC
region. It is noteworthy that for the NDs with 50% anionic lipids
the protein-to-ND ratio does not affect the overall binding mode
(binding mode III in Fig. 5e). In line with an exposed NAC
region, the ThT data for these NDs at low αS-to-ND ratios are
consistently showing no effect on aggregation half-times (Fig. 5i).
The data at higher ratios are less reproducible and show a slight
tendency to prolonged elongation rates. Unlike for 100% POPG
NDs and in line with the previously discussed moderate effects of
50% POPG NDs on the overall aggregation process, we did not
observe accelerated αS nucleation in the presence of NDs with
50% POPG nor a clear perturbation of fibril elongation in seeded
experiments (see Supplementary Fig. 7 for data and a more
detailed discussion).
Discussion
Overall, our data demonstrate that the ND system allows to study
the interaction of αS with stable, planar membranes in a
quantitative, and site-resolved way. Many aspects of the mem-
brane association are similar to previously reported interactions
with micelles or SUVs, suggesting that features that distinguish
the different membrane mimetics, such as curvature, physical
bilayer borders, and potential vesicle disruption do not
substantially alter the membrane binding properties of αS.
The convenient handling, reliable, and unique quantification































Fig. 6 Model of the influence of different NDs on the αS aggregation pathways and speculations regarding their potential implication in the context of cell/
vesicle membranes. Four scenarios are depicted summarizing our in vitro data in respect to membrane surface charge and accessibility. (Note that
schemes with nanodiscs and aggregation pathways are based on our findings, while possible implications in respect to physiological membranes are purely
speculative.) In cases where membranes/NDs with only low charge densities are present (scenario 1 and 2) αS interacts with its N-terminal residues and
forms an exchanging equilibrium between soluble and membrane associated αS monomers (binding mode III in Fig. 5e). This equilibrium does not seem to
strongly interfere with the slow process of αS nucleation, it may however (slightly) decrease the pool of free monomers available for fibril formation.
Although physiological membranes, in general, have a lower average charge density (represented by the upper panels), specific, abnormal, and/or
stochastic processes may also lead to highly charged lipid clusters (lower panels). In the unlikely case of not limiting surface access (scenario 3) αS will
interact in a binding mode that will largely inhibit both αS nucleation and fibril elongation (binding mode II in Fig. 5i). In cases with only local charge
clusters, several αS monomers may compete for the limited highly charged membrane surface area (scenario 4). This binding mode (Fig. 5e mode I) can
bring exposed NAC regions of several αS monomers in close proximity and accelerate the amyloid fibril nucleation process
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for a broad range of biophysical techniques also enabled us to
obtain a direct correlation between the structural and kinetic
properties of the different membrane-binding modes and their
consequences for αS amyloid fibril formation. In summary, our
data show that (i) the N-terminal αS region interacts rather
similarly with NDs composed of 100% or 50% anionic lipids; (ii)
for 100% anionic lipids, the αS can adopt a substantially expanded
binding mode as compared with 50% anionic lipid content,
leading to considerably higher global affinities; (iii) the exchange
rate between free αS in solution and membrane-bound αS is slow
in the 100% charged case and likely to be faster in the 50% case;
(iv) region-specific membrane affinities (especially the NAC
region) are correlated with aggregation properties; (v) with suf-
ficient excess of lipids and sufficient charge density, NDs can
inhibit primary nucleation and fibril elongation by sequestering
monomers out of solution; (vi) competition of αS monomers for
highly charged lipid surface generates a membrane-bound αS
conformation that can induce primary nucleation; and (vii) the
number of αS monomers that are brought together by one ND
and which can promote amyloid fibril nucleation is in the order
of about 8 αS molecules.
Although our in vitro data directly support the above drawn
conclusions, we can only speculate about which (if any) role these
factors may have in vivo. Figure 6 summarizes the experimentally
determined molecular and kinetic determinants of membrane-
modulated αS aggregation and speculates about their potential
physiological roles. In general, it should be noted that, in our
study, the strongest effects were observed at lipid charge densities
well above the average lipid compositions of native membranes.
However, the normally found high lipid diffusion rates in
physiological membranes may generate clusters of higher negative
charges that may form spontaneously or be induced by an
initially transient αS interaction. For the latter, the N-terminal
acetylation may have an important role, as it increases membrane
interaction at native lipid charge densities. Our data suggest that
clusters of around 60–80 negatively charged lipids suffice to form
a strong interaction (this may however not be the lower limit and
specific physiological lipids not tested here may have even
stronger effects). Sporadically formed charged lipid clusters could
also induce a competition of several αS monomers for the
accessible surface area. Our data show that due to the different
residue-specific membrane affinities, this will generate a binding
mode that, once the rather low αS critical oligomerization num-
ber is reached, can act as an aggregation seed. Such a scenario
could promote the initial step of primary nucleation in the
pathogenesis of Parkinson’s disease and is in line with recent
in vivo findings, suggesting that shielding αS from membrane
interactions can inhibit initial steps of amyloid fibril formation
including the formation of cell-toxic species56.
Methods
αS expression and purification. Codon-optimized αS in the pT7-7 vector was
expressed in Escherichia coli BL21 DE3. For acetylated αS, the N-terminal
acetylation enzyme NatB from Schizosaccharomyces pombe, which will selectively
acetylate αS at the free amino group of the N-terminus, was coexpressed in a
second vector, pNatB57. Expression was conducted in 50 mM phosphate-buffered
2YT-medium (pH 7.2) with 0.4% glycerol and 2 mM MgCl2, protein production
was induced at OD 1-1.2 with 1 mM Isopropyl β-D-1-thiogalactopyranoside
(IPTG) and run for 4 h at 37 °C. For 15N-labeled protein, αS or acetylated αS was
expressed in M9 medium with 0.2% 15NH4Cl.
Sparsely labeled αS for DNP experiments was non-acetylated, expression was
done in a similar way, in M9 medium using 0.4% [2-13C]-glucose and 0.2%
15NH4Cl. Isotope labeling of Phe, Gln, Glu, Pro, Asn, Asp, Met, Thr, Lys, and Ile
was suppressed by supplementing sufficient quantities (150 µg ml–1 of each) of
these unlabeled amino acids in the expression media as reported previously51.
Purification of αS or acetylated αS was carried out as previously described58,
some changes to the original protocol have been made. Except for sparse labeled αS
for which previous lysis in 20 mM Tris-HCl pH 8.0, 1 mM EDTA was done, cell
lysis and release of αS or acetylated αS was performed by directly boiling the frozen
cell pellet at 95 °C in a threefold volume of 20 mM sodium phosphate buffer, pH
7.4, for 30 min. Thermostable αS or acetylated αS remained in the supernatant after
30 min of centrifugation at 15,000 × g and 4 °C and was subsequently subjected to
an ammonium sulfate precipitation by slowly adding saturated ammonium sulfate
solution to 50% saturation at 4 °C. Precipitated protein was pelleted at 15,000 × g
and 4 °C, dissolved in 50 ml of 50 mM Tris-HCl pH 8, sterile-filtered, and loaded
onto an ion exchange chromatography column (HiTrap Q FF, GE Healthcare),
where αS or acetylated αS eluted at around 300 mM NaCl in 50 mM Tris-HCl pH
8. Elution fractions containing αS or acetylated αS were subjected to another
ammonium sulfate precipitation and finally purified by a SEC run (Superdex 75 10/
300, GE Healthcare) in 20 mM sodium phosphate pH 7.4, 50 mM NaCl.
N-terminal acetylation of acetyl-αS was checked by high-performance liquid
chromatography, mass spectrometry, and NMR, proved to be about 95% when co-
expressed with NatB.
Membrane scaffold protein expression and purification. As reported before59,
E. coli BL21 (DE3) were transformed with MSP1D1 or MSP1D1ΔH5 plasmid DNA
in vector pET28a. Cells were grown in lysogeny broth (LB) medium, induced by 1
mM IPTG at an optical density of 0.7, and incubated 5–6 h at 37 °C, then pelleted
down. Cells were resuspended in 50 mM Tris-HCl pH 8, 500 mM NaCl (buffer B)
supplemented with 6 M GdnHCl and EDTA-free Complete protease inhibitors
(Macherey–Nagel) lysed by sonication (Bandelin Sonopuls MS72 probe), cen-
trifuged at 17,000 × g for 1 h (Beckman J2-21 rotor JA-20.1) and incubated 1 h with
previously equilibrated 2.5 ml Ni-NTA agarose resin/3 l culture (Macherey–Nagel).
Column was washed with 4 column volumes (CV) buffer B, 4 CV buffer B sup-
plemented with 1% Triton X-100, 4 CV buffer B+ 60 mM Na-cholate, 4 CV buffer
B, and 4 CV buffer B+ 20 mM imidazole. Four fractions of 1 CV were eluted with
250 mM imidazole. The whole process was kept at 4 °C in a cold room. The elution
fractions were pooled and dialysed against 100-fold 200 mM Tris-HCl pH 7.5, 100
mM NaCl. N-terminal His-tag was cleaved using tobacco etch virus (TEV) protease
incubated overnight at 4 °C. ΔHis-MSP was separated by immobilized metal affi-
nity chromatography (IMAC) and concentrated to the desired molarity using a
Vivaspin centrifugal device of 10 kDa molecular weight cutoff (MWCO).
ND assembly. NDs were assembled according to established protocols31. In short,
lipids’ chloroform stocks were dried under nitrogen flow to obtain a lipid film and
stored under vacuum overnight. ΔHis-MSP1D1 or MSP1D1ΔH5 and the
appropriate amount of lipids (Avanti Polar Lipids) solubilized in 60 mM
Na-cholate were mixed together in 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM
EDTA. The scaffold-to-lipids molar ratio was calculated from geometrical
considerations. 20% w/v of previously washed Biobeads SM-2 (Biorad) were added
and the mixture incubated at room temperature overnight. The Biobeads were
removed by centrifugation and once again 20% w/v were added for an additional
4–5 h. Finally, they were purified by SEC on a HiLoad 16/600 Superdex 200 pg
column (GE Healthcare) equilibrated with 20 mM sodium phosphate pH 7.4, 50
mM NaCl using a Äkta pure device at a flow rate of 1 ml min–1. The quality of NDs
preparation was check by the SEC chromatogram and by DLS (PSS Nicomp). NDs
were concentrated to the desired molarity using a Vivaspin centrifugal device of 10
kDa MWCO. It is noteworthy that concentration of NDs can be rather accurately
determined using the 280 nm absorbance of the membrane scaffold proteins and
lipid concentration can be estimated using the geometrically ideal lipid amount per
ND, i.e., 156 DMPC molecules or 150 POPG molecules.
Biolayer interferometry. NDs were immobilized on the sensor surface of amine
reactive biosensors (AG2R) (fortéBIO, PALL Life Science) after 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide/N-hydroxysulfoxuccinimide (EDC/NHS)
activation to a final level between 1.2 and 1.8 nm depending on the NDs type using
an Octet RED96 instrument (fortéBIO, PALL Life Science). All biosensors were
quenched with 1M ethanolamine for 3 min. All experiments were carried out in
multi cycle kinetics at 25 °C. Association of αS in running buffer (20 mM sodium
phosphate pH 7.4, 50 mM NaCl) on NDs and reference biosensors was recorded
for 120 s, followed by a dissociation phase of 360 s. Sensorgrams were double
referenced using the reference biosensors and a buffer cycle. Steady-state analysis
was realized by fitting the αS concentration dependency of the highest response
with a simple 1:1 binding model. After normalization, all on and off curves were
fitted against simple exponential build-up or decays and led to similar on- and
off-rates.
Solution NMR spectroscopy. Solution NMR experiments were performed on a
Bruker Avance III HD+ spectrometer operating at 600MHz 1H Larmor frequency,
equipped with a triple resonance TCI (1H, 13C, 15N) cryoprobe and shielded
z-gradients. If not stated otherwise, all experiments were recorded at 10 °C with an
αS concentration of 50 µM in 20 mM sodium phosphate pH 7.4, 50 mM NaCl, 10%
(v/v) 2H2O, and ND concentration was set to 25 µM (one αS per membrane
leaflet). All [1H-15N]-TROSY-HSQC NMR spectra were acquired with 32 scans
and 256 indirect increments, processed with TOPSPIN 3.2 (Bruker) and analyzed
with CCPN60. A full list of measured samples can be found in Supplementary
Table 1. For attenuation profiles, peaks were automatically integrated and the ratio
of volumes in the presence and absence of NDs plotted against the primary
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sequence. The raw data without normalization, multi-residue averaging, or manual
compensation of peak position is shown. Negative values are results of noise
contributions and/or slight peak shifts. Outliers as results of peak overlap and/or
ambiguities were removed.
ThT fluorescence aggregation assays. Three types of aggregation assays were
used in this study. Unless otherwise stated, a setup under conditions where αS
amyloid fibrils form spontaneously, mainly by interface-driven nucleation and
subsequent amplification through fragmentation, was chosen. Experiments under
these conditions mainly report on the potential interference of NDs on the lipid-
independent aggregation pathways. Here, 50 µM of αS or acetylated αS was mixed
with either 25 µM (2:1), 3.125 µM (16:1), or 0.781 µM (64:1) NDs with different
lipid compositions. Assays were conducted in 20 mM sodium phosphate buffer pH
7.4 or 20 mM acetate buffer pH 5.3 with 50 mM NaCl, 0.02% NaN3, and 10 µM
ThT. Unless otherwise stated, triplicates of 120 µl were pipetted into 96-well half-
area well plates with non-binding surface (Corning No. 3881, black, clear bottom)
containing a glass ball (2.85–3.45 mm diameter) for mixing and incubated at 37 °C
for up to 7 days. Orbital shaking at 217 r.p.m. was used for 15 s every 20 min. ThT
fluorescence was excited at 445 nm and measured at 485 nm every 20 min with 15 s
of shaking before the measurement in a plate reader (Tecan Spark 10M or Tecan
infinite M1000PRO).
Nucleation-sensitive assays: Under that minimize the intrinsic nucleation rate
(quiescent conditions and protein repellent plate surfaces), lipid bilayers in the
form of SUVs can accelerate the nucleation of αS amyloid fibrils29. In order to
determine whether NDs can have a similarly accelerating effect, we performed ThT
aggregation experiments under similar conditions, i.e., where no αS aggregation
should be detected in the absence of lipids. These experiments were performed at
mildly acidic pH (5.3), as it was recently shown that under these conditions, αS
amyloid fibrils can amplify autocatalytically through surface-catalyzed secondary
nucleation49,61. This should in principle enable even very low primary nucleation
rates to be detected through autocatalytic amplification.
Elongation-sensitive assays: Seeded experiments using preformed αS fibrils were
used to measure the effect of NDs on fibril elongation. Fibril seeds of αS or
acetylated αS were prepared as follows: 300 µl of 100 µM αS or acetylated αS was
fibrillated at 37 °C and 800 r.p.m. for 3 days in a 2 ml tube containing a glass ball in
a Thermomixer (Eppendorf). The fibril solution was diluted to 50 µM and
sonicated with a tip sonicator (Bandelin Sonopuls HD3200, BANDELIN electronic)
at 10% power (20W) for 60 s, with 1 s pulses on and 4 s off in between. Seed
solution was diluted 20-fold for the aggregation assays (2.5 µM, 5%).
Assay analysis: Kinetic curves were corrected by subtracting the curve of buffer
(containing NDs) in the presence of ThT and normalized to the highest
fluorescence intensity (in line with comparable fibril mass seen in SDS-
polyacrylamide gel electrophoresis after the aggregation assay). The corresponding
triplicates are shown as transparent circles in order to visualize the reproducibility
of each experiment. Data fits were obtained using a simple sigmoidal function and
the Abscissa 2D plot tool (by Rüdiger Brühl). In the case of quiescent nucleation
and seeded assays, no normalization was applied and data were recorded without
the presence of glass balls and without plate shaking.
SDS–polyacrylamide gel electrophoresis. In order to compare the amounts of
soluble and fibrillated αS or acetylated αS in the aggregation samples, 100 µl of each
triplicate sample were taken out of the well plate, combined in 1.5 ml tubes, and
spun down at 20,000 × g and 20 °C for 30 min. Supernatants (~ 290 µl) were
removed and pellets were resuspended in 280 µl buffer, and SDS-sample buffer (4-
fold) was added. Samples were boiled for 15 min at 98 °C and subsequently 10 µl
were loaded onto a 15% SDS-gel together with standards of αS or acetylated αS and
NDs.
DNP NMR spectroscopy. Magic-angle spinning solid-state DNP experiments
were performed on a Bruker Avance III HD spectrometer operating at 600MHz,
equipped with a 395.18 GHz second-harmonic gyrotron and a 3.2 mm 1H,13C,15N
triple resonance low-temperature magic-angle-spinning probe. Data were collected
at 100 K, 9 kHz magic angle spinning speed, and 9W continuous-wave microwave
power. The samples were prepared from sparsely labeled non-acetylated αS (250
µg) in the presence or in the absence of 2:1 molar ratio of 100% POPG NDs, and
filled into 3.2 mm sapphire rotors. Final buffer conditions in the sample were 15
mM sodium phosphate pH 7.4, 25 mM sodium chloride, 30% 2H2O, 60% glycerol-
d6, and 2.5 mM AMUPOL62. Two-dimensional [13C-13C]-proton-driven spin
diffusion experiments with 1 s mixing time were performed. It is noteworthy that
this DNP setup also allows a more detailed quantatitive analysis of different αS
conformational ensembles and the effects of different polarization transfers as
well63. 1H decoupling using SPINAL64 with a decoupling field of 104 kHz was
employed during evolution and detection periods. Both experiments were con-
ducted using 300 t1 increments with 16 and 48 scans each for αS in the absence and
in the presence of NDs, respectively. A recycle delay of 5 s was used in both
experiments. Both spectra were processed using Topspin 3.2 (Bruker) using
identical parameters with squared and shifted sine bell function (qsine 2.5) for
apodization.
MD simulations. As starting conformation for the MD simulations, the NMR
structure of micelle-bound αS (PDB 1XQ8) was used, considering only the first 61
residues in order to concentrate on the membrane-binding region of αS.
The Amber99sb-ILDN force field64 was used for αS, which was simulated in its
non-acetylated form (i.e., with NH3+ at the N-terminus) and with a C-terminal
N-methyl amide capping group to account for the fact that αS would continue
beyond residue 61. All lysine side chains were modeled as positively charged,
glutamate and aspartate as negatively charged, whereas glutamine and histidine
residues were considered to be neutral corresponding to pH 7.4. The protein was
placed either 0.5 nm or 1.5 nm above the membrane surface. A starting orientation
with the negatively charged side chains pointing away from the membrane and the
lysine side chains being oriented toward the membrane surface were chosen
(Fig. 4b). For modeling the lipid bilayer, membrane patches consisting of
POPC/POPG (1:1) or DMPC/DMPG (1:1) involving 512 lipids (256 lipids per
leaflet) were built using CHARMM-GUI65 and modeled with Slipids force field
parameters66,67. Before αS was added, both lipid bilayers were solvated and
simulated for 500 ns (POPC/POPG) or 1000 ns (DMPC/DMPG) to obtain relaxed
membranes. Here, the same simulation procedure was employed as described
below. αS was placed above the membrane, the protein–membrane complex
solvated using the TIP3 water model, and Na+ and Cl– were added to neutralize
the system and to mimic the Na+ concentration used in the experiments. The ion
parameters of Smith and Dang68 were used. The system was then subjected to
steepest descent energy minimization, followed by MD equilibration in
the constant number (N), volume (V) and temperature (T) (NVT) ensemble for 1
ns at 10 °C using the V-rescale thermostat69 with a time constant of 0.5 ps and
separate temperature coupling for the protein, membrane, and
water/ions. Afterwards, 1 ns of constant number (N), pressure (P) and temperature
(T) (NPT) equilibration was performed using the Nose–Hoover thermostat70,71
and Parrinello–Rahman barostat72 with semi-isotropic pressure scaling, a reference
pressure of 1 bar, a time constant of 10.0 ps, and an isothermal compressibility of
4.5 × 10–5 bar–1. During both equilibration steps, restraints were applied to the
positions of the P-atoms of the lipids and terminal C-atoms of their tails with a
force constant of 1000 kJ mol–1 nm−2. All bond lengths were constrained using the
Lincs algorithm73. The Coulombic interactions were calculated using the Particle
mesh Ewald method74,75 with a cutoff value of 1.0 nm for the short-range
interactions and a Fourier spacing of 0.12 nm. The cutoff value for the van der
Waals interactions was set at 1.4 nm. Periodic boundary conditions were employed
in all directions. For the MD production runs, the same settings as for the NPT
equilibration were used, except that all position restraints were removed. All MD
simulations were performed at 10 °C with a time step of 2 fs for integration using
the GROMACS 4.6 MD package76. For the analysis, which was performed using
Gromacs and Membrainy tools77, only the last 250 ns of each production run
was used.
A full list of simulations can be found in Supplementary Table 2.
Size exclusion chromatography. For analytical SEC, an Akta pure systems
equipped with a Superdex 200 13/300 gl column (GE Healthcare) was used. After
equilibration with two column volumes of running buffer (20 mM sodium
phosphate pH 7.4, 50 mM NaCl), samples of approximately 5 µM NDs, 10 µM αS,
or a mix thereof were injected at a flowrate of 0.5 ml min–1. In order to assay
stability of the NDs in the presence of αS, the same mix was incubated 24 h at room
temperature and injected afterwards.
Differential scanning calorimetry. Samples of approximately 5 µM NDs of dif-
ferent types (and if stated 10 µM αS) in running buffer (20 mM sodium phosphate
pH 7.4, 50 mM NaCl) were degassed for at least 20 min at 30 °C and measured in a
Microcal VP-DSC instrument (Malvern Instruments). After equilibration and a
pre-scan delay of 20 min, the thermograms were acquired up-scan from 5 °C to 45 °
C at a scanning rate of 0.5 °C min–1 and corrected by subtracting the thermogram
of buffer and adjusting the baseline to zero at 45 °C (y-axis molarity refers to
estimated amounts of lipids).
Atomic force microscopy. AFM images were taken in air, using a Nanowizard III
atomic force microscope (JPK, Berlin). Samples were taken at the end of
aggregation experiments and diluted in pure water to approximately 1 µM protein
concentration. Ten microliters of sample were added onto freshly cleaved mica and
left to dry. Then, they were gently rinsed with water to remove excess salt. Imaging
was performed using tapping mode with NSC 36 cantilevers (MikroMasch), with
resonant frequencies between 70 and 150 kHz.
Data availability. The datasets generated during and/or analysed during the
current study are available from the corresponding author on request. NMR
chemical shift asignments are in line with data already deposited in the Biological
Magnetic Resonance Data Bank, e.g., under accession codes 19350 (acetlyated) and
19337 (non-acetylated)78.
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